Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs IMETELSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs IMETELSTAT: Safety Overview

Metric IFOSFAMIDE IMETELSTAT
Total FAERS Reports 17,004 137
Deaths Reported 3,365 18
Death Rate 19.8% 13.1%
Hospitalizations 5,230 37
Average Patient Age 36.2 yrs 77.0 yrs
% Female Patients 41.7% 43.3%
FDA Approval Date Apr 4, 2007 Jun 6, 2024
Manufacturer Baxter Healthcare Corporation Geron Corporation
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription